|
Biotest Biopharmaceuticals |
|
|
5800 Park of Commerce Blvd., N.W. Boca Raton, FL 33487 USA phone:561-989-5800 fax:561-989-5801
|
|
| Symbol |
private |
| Founded |
2007 |
| Employees |
|
|
|
| www.biotestpharma.com
|
|
|
|
 |
| Summary Description |
| Hyperimmune globulin
|
 |
| Management |
|
| |
|
|
| |
|
| Keywords |
| pharmaceuticals, biotherapeutic products, protein, hematology, immunology |
|
|
|
| Description |
|
Nabi-HB [Hepatitis B Immune Globulin (Human)] is a hyperimmune globulin that contains antibodies to hepatitis B surface antigen (anti-HBs).
Nabi-HB is indicated for the treatment of acute exposure to blood containing hepatitis B surface antigen (HBsAg), perinatal exposure of infants born to HBsAg-positive mothers, sexual exposure to HBsAg-positive persons and household exposure to persons with acute HBV infection. Hepatitis B Immune Globulin (Human) products provide passive immunization for individuals exposed to the hepatitis B virus as evidenced by a reduction in the attack rate by hepatitis B following use. Clinical studies conducted prior to 1983 with hepatitis B immune globulins similar to Nabi-HB indicate the advantage of simultaneous administration of hepatitis B Vaccine and hepatitis B Immune Globulin (Human). |
 |
| Technology / Differentiation |
| Vaccine and antibody technologies; immunotherapy. |
 |
| Market / Customers |
PhosLo (calcium acetate), Nabi-HB (Hepatitis B Immune Globulin), and Aloprim (allopurinol sodium). Products focus on the treatment of hyperphosphatemia (elevated serum phosphorus levels) in patients with end-stage renal disease; the prevention of Hepatitis B infection following acute exposure to the Hepatitis B virus; and management of elevated serum and urinary uric acid levels in patients receiving chemotherapy.
|
 |
|
|
|
|
|
|